Vladimir Skljarevski

Author PubWeight™ 15.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 2009 2.69
2 Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain 2012 1.88
3 Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain 2013 1.64
4 A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract 2011 1.50
5 Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials. Diabetes Care 2007 1.03
6 Correlation of vibratory quantitative sensory testing and nerve conduction studies in patients with diabetes. Muscle Nerve 2007 0.94
7 Predictors of premature discontinuation of treatment in multiple disease states. Patient Prefer Adherence 2009 0.90
8 Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. Mayo Clin Proc 2011 0.89
9 A closer look at the baseline-observation-carried-forward (BOCF). Patient Prefer Adherence 2010 0.88
10 Duloxetine versus placebo in the treatment of patients with diabetic neuropathic pain in China. Chin Med J (Engl) 2010 0.84
11 Efficacy of duloxetine versus alternative oral therapies: an indirect comparison of randomised clinical trials in chronic low back pain. Eur Spine J 2013 0.79
12 A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative. Pain 2012 0.78
13 A stroke-like presentation of glioblastoma multiforme. J Stroke Cerebrovasc Dis 2003 0.78